Hilleman Laboratories’ new S$80m vaccine manufacturing plant to be fully operational by early 2023

Top Lifetime Deals - Business Software Ai Writer, SEO, Blogging, Email & More

Save up to 90% Discount On Business Software such AI Writer & CRMs

Singapore is set to have a new facility for the development of new vaccines to build up its defences against disease outbreaks. It’s part of an $80-million vaccine and biologics hub by vaccine research organisation Hilleman Laboratories, and will be fully operational by early 2023. Trade and Industry Minister Gan Kim Yong was at the groundbreaking ceremony. The facility is the first by the company and will supply vaccine materials for clinical trials. Up to 50 staff, comprising scientists, engineers and managers, will be hired to run the place.

Subscribe to our channel here: https://cna.asia/youtubesub

Subscribe to our news service on Telegram: https://cna.asia/telegram

Follow us:
CNA: https://cna.asia
CNA Lifestyle: http://www.cnalifestyle.com
Facebook: https://www.facebook.com/channelnewsasia
Instagram: https://www.instagram.com/channelnewsasia
Twitter: https://www.twitter.com/channelnewsasia

You May Also Like